KAZIA THERAPEUTICS

Welcome to the Brand page for “KAZIA THERAPEUTICS”, which is offered here for Pharmaceutical preparations, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes;chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals;the wording kazia has no meaning in a foreign language.;therapeutics;scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services;.

Its status is currently believed to be active. Its class is unavailable. “KAZIA THERAPEUTICS” is believed to be currently owned by “Kazia Therapeutics Limited”.